Current Opinion in Hematology

(The median citation count of Current Opinion in Hematology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
An update on the pathophysiology of immune thrombocytopenia84
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies47
Structural organization of the bone marrow and its role in hematopoiesis39
Brothers in arms: platelets and neutrophils in ischemic stroke32
Mechanisms of immunothrombosis in COVID-1931
The rebirth of the contact pathway: a new therapeutic target31
Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease31
Advances in chimeric antigen receptor T cells23
Human babesiosis: recent advances and future challenges23
The interaction between the complement system and hemostatic factors21
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases20
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes18
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms17
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia17
Update on the pathophysiology of transfusion-related acute lung injury16
Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology16
Germline mutations in MDS/AML predisposition disorders15
Role of complement in alloimmunization and hyperhemolysis14
The Nlrp3 inflammasome – the evolving story of its positive and negative effects on hematopoiesis14
Genetic heterogeneity and clonal evolution in acute myeloid leukemia14
Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants13
Systems analysis of hematopoiesis using single-cell lineage tracing12
The N6-methyladenosine RNA modification in acute myeloid leukemia12
Recent advances in factor XII structure and function12
Prothrombotic state associated with preeclampsia11
An expanded role for dipeptidyl peptidase 4 in cell regulation11
Ineffective erythropoiesis in sickle cell disease: new insights and future implications11
Symmetric and asymmetric activation of hematopoietic stem cells11
Human hematopoiesis: aging and leukemogenic risk11
Mouse models of vascular development and disease10
The congenital dyserythropoieitic anemias: genetics and pathophysiology10
Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and management10
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia10
Protein S: function, regulation, and clinical perspectives9
The protein C pathways9
VEXAS: where do we stand 2 years later?9
Casting a NET on cancer: the multiple roles for neutrophil extracellular traps in cancer9
Cellular components of the hematopoietic niche and their regulation of hematopoietic stem cell function9
Complement contributions to COVID-198
Blood in the water: recent uses of zebrafish to study myeloid biology8
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies8
Regulation and importance of factor VIII levels in hemophilia A carriers8
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy8
Translational control by heme-regulated elF2α kinase during erythropoiesis8
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods8
The significance of CUX1 and chromosome 7 in myeloid malignancies8
A zebrafish toolbox for biomechanical signaling in cardiovascular development and disease7
Heterogeneity of fetal hemoglobin production in adult red blood cells7
Immunomodulatory roles of red blood cells7
Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications7
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis7
Optimizing leukapheresis product yield and purity for blood cell-based gene and immune effector cell therapy6
Immunologic effects of red blood cell and platelet transfusions in neonates6
Thrombosis in myeloproliferative neoplasms: update in pathophysiology6
Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions6
Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia6
Proteomic/transcriptomic analysis of erythropoiesis6
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases6
Clonal hematopoiesis in hematopoietic stem cell transplantation6
PIEZO1, sensing the touch during erythropoiesis6
Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells6
Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance6
Hormetic endoplasmic reticulum stress in hematopoietic stem cells6
How haematopoiesis research became a fertile ground for regulatory network biology as pioneered by Eric Davidson5
Enhancing cardiovascular research with whole-organ imaging5
Deciphering transcriptional and functional heterogeneity in hematopoiesis with single-cell genomics5
Clinical trials for chimeric antigen receptor T-cell therapy: lessons learned and future directions5
Congenital neutropenia: disease models guiding new treatment strategies5
Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology5
Significance and management of isolated distal deep vein thrombosis5
Novel concepts in red blood cell clearance5
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease5
Heterogeneity and origins of myeloid cells4
Azacitidine maintenance in AML post induction and posttransplant4
Erythroid cells and malaria parasites: it's a match!4
Venous thromboembolism in the hormonal milieu4
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications4
Global perspectives on cellular therapy for children with sickle cell disease4
Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remission4
The role of biomarkers in risk stratification, treatment and outcome in acute GVHD4
Platelet mitochondria: the mighty few4
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients4
Updates in diagnosis of the inherited platelet disorders3
Methods to quantify endothelial cell front-rear polarity in vivo and in vitro3
Local and systemic features of ILC immunometabolism3
Role of p53 in regulation of hematopoiesis in health and disease3
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance3
The impact of prenatal inflammation on hematopoietic development3
Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation3
The new metabolic needs of hematopoietic stem cells3
Novel developments in chronic myeloid leukaemia3
Chediak-Higashi syndrome3
Single-cell RNA sequencing to study vascular diversity and function3
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia3
Erythrocyte pyruvate kinase activation in red cell disorders3
Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review2
Circulating platelet count and glycans2
The new world: hematopoietic stem cell transplant during a pandemic2
Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions2
Iron status of blood donors2
Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome2
Red cell extracellular vesicles and coagulation activation pathways2
Splicing regulation in hematopoiesis2
Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices2
Platelet mechanosensing as key to understanding platelet function2
Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication2
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells2
Hematopoietic stem cell collection for sickle cell disease gene therapy2
A closer look at adipose tissue lymphatics and their markers2
Molecular and functional characteristics of megakaryocytes and platelets in aging2
No time to die? Intrinsic apoptosis signaling in hematopoietic stem and progenitor cells and therapeutic implications2
Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters2
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implicati2
Meningeal Lymphatic vasculature in health and disease2
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis2